US 10287297
Epoxyazulene derivatives useful for treating cancer and diabetes
granted A61PA61P3/10A61P35/02
Quick answer
US patent 10287297 (Epoxyazulene derivatives useful for treating cancer and diabetes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P3/10, A61P35/02